RxDoctor Payments Data

John Fallon

Internal Medicine · Boston, MANPI 1609816883

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,715,615 of the $1,792,373 with a category attached, or 95.7%. Insulet Corporation accounts for 93.6% of it on its own, with 2 other manufacturers making up the rest. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,792,373in general payments, 2019–2025

Across 21 payments — averaging $85,351 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$1.7M
  • AMAG Pharmaceuticals, Inc.$113K
  • Renovia Inc$815

What the payments were for

  • Consulting fees$75,5114%
  • Speaking & faculty fees$1,715,61596%
  • Travel & lodging$9180%
  • Food & beverage$3290%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Insulet Corporation9$1,678,547
AMAG Pharmaceuticals, Inc.8$113,011
Renovia Inc4$815

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,792,373 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Other internal medicine in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →